Reply to: "Negotiating better discounts for DAA therapy is critical to achieve HCV elimination by 2030".

导出 LinkOut

翻译打印收藏纠错

作者： Ruth,Zimmermann ^[1] ; Christian,Kollan ^[2] ; Patrick,Ingiliz ^[3] ; Stefan,Mauss ^[4] ; Daniel,Schmidt ^[5] ; Viviane,Bremer ^[2]

作者单位： Department of Infectious Disease Epidemiology, Robert Koch Institute, Germany. Electronic address: ZimmermannR@rki.de. ^[1] Department of Infectious Disease Epidemiology, Robert Koch Institute, Germany. ^[2] Centre for Infectiology, Berlin, Germany. ^[3] Centre for HIV and Hepatogastroenterology, Duesseldorf, Germany. ^[4] Department of Infectious Disease Epidemiology, Robert Koch Institute, Germany; Charité University Medicine, Berlin, Germany. ^[5]

主题词抗病毒药(Antiviral Agents);丙型肝炎(Hepatitis C);人类(Humans);谈判(Negotiating)

DOI 10.1016/j.jhep.2017.03.033

PMID 28412291

发布时间 2018-12-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交